World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
57
Citations
14139
World Ranking
3546
National Ranking
259

Maura Dandri publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Maura Dandri sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 247 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Maura Dandri D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Maura Dandri sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 57 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Maura Dandri is affiliated with Universität Hamburg in Germany and specializes in medical research with a primary focus on hepatitis B virus and related liver diseases. Their work intersects several fields, prominently medicine, epidemiology, and hepatology, with additional contributions in molecular biology, infectious diseases, and immunology.

The scientist's recent publications highlight key areas of study in viral infections and liver pathologies. Notable papers include:

  • "Neuropathology of patients with COVID-19 in Germany: a post-mortem case series" (2020) published in The Lancet Neurology
  • "A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook" (2022) published in Nature Reviews Gastroenterology & Hepatology
  • "Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial" (2022) published in The Lancet Infectious Diseases
  • "Epigenetic modulation in chronic hepatitis B virus infection" (2020) published in Seminars in Immunopathology
  • "48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection" (2020) published in Journal of Hepatology

Their research contributions extensively cover the following topics:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Viral Infections and Outbreaks Research
  • Immunotherapy and Immune Responses
  • Molecular Biology Techniques and Applications

Maura Dandri frequently collaborates with several co-authors, including:

  • Lena Allweiss
  • Marc Lütgehetmann
  • Tassilo Volz
  • Katja Giersch
  • Annika Volmari

Their publications are commonly found in several scientific venues, demonstrating a focus on hepatology and gastroenterology-related journals. Prominent publication venues include:

  • Journal of Hepatology
  • Zeitschrift für Gastroenterologie
  • bioRxiv (Cold Spring Harbor Laboratory)
  • JHEP Reports
  • Liver International

Maura Dandri's research domain is situated primarily within medicine, emphasizing epidemiological approaches to viral hepatitis, chronic liver disease mechanisms, and therapeutic development. Their work on the epigenetic modulation of chronic hepatitis B virus infection contributes to understanding how viral persistence and host interactions influence disease progression.

Their collaborations and publication record reflect an engagement in multidisciplinary aspects of liver disease research, covering molecular biology tools, immune response mechanisms, and clinical trial data related to antiviral treatments.

Best Publications

  • Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.

    Jakob Matschke;Marc Lütgehetmann;Christian Hagel;Jan P Sperhake

  • Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

    Julie Lucifora;Yuchen Xia;Florian Reisinger;Ke Zhang

  • Control of cccDNA function in hepatitis B virus infection

    Massimo Levrero;Teresa Pollicino;Jorg Petersen;Laura Belloni

  • IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

    Laura Belloni;Lena Allweiss;Francesca Guerrieri;Natalia Pediconi

  • Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

    Karsten Wursthorn;Marc Lutgehetmann;Maura Dandri;Tassilo Volz

  • Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    Giovanni Raimondo;Stephen Locarnini;Teresa Pollicino;Massimo Levrero

  • Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

    Maura Dandri;Martin R. Burda;Eva Török;Joerg M. Pollok

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

    Joerg Petersen;Maura Dandri;Walter Mier;Marc Lütgehetmann

  • The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus

    Tassilo Volz;Lena Allweiss;Mounira Ben MBarek;Michael Warlich

  • Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

    Markus Cornberg;Anna Suk Fong Lok;Norah A. Terrault;Fabien Zoulim

  • Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis.

    Anna Worthmann;Clara John;Malte Christoph Rühlemann;Miriam Baguhl

  • New insight in the pathobiology of hepatitis B virus infection

    Maura Dandri;Stephen Locarnini

  • Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.

    Marc Lütgehetmann;Lida V. Mancke;Tassilo Volz;Martina Helbig

  • Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.

    Tassilo Volz;Marc Lutgehetmann;Paul Wachtler;Anna Jacob

  • The Role of cccDNA in HBV Maintenance

    Lena Allweiss;Maura Dandri

  • Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.

    Lena Allweiss;Tassilo Volz;Katja Giersch;Janine Kah

  • Serum HBV pgRNA as a clinical marker for cccDNA activity.

    Katja Giersch;Lena Allweiss;Tassilo Volz;Maura Dandri

  • The replication cycle of hepatitis B virus

    Stephan Urban;Andreas Schulze;Maura Dandri;Joerg Petersen

  • Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.

    Marc Lütgehetmann;Till Bornscheuer;Tassilo Volz;Lena Allweiss

Frequent Co-Authors

Marc Lütgehetmann
Marc Lütgehetmann University Medical Center Hamburg-Eppendorf
Stephan Urban
Stephan Urban University Hospital Heidelberg
Ansgar W. Lohse
Ansgar W. Lohse Universität Hamburg
Antonio Bertoletti
Antonio Bertoletti Duke NUS Graduate Medical School
Camille Sureau
Camille Sureau Centre national de la recherche scientifique, CNRS
Ulrike Protzer
Ulrike Protzer Technical University of Munich
Ralf Bartenschlager
Ralf Bartenschlager Heidelberg University
Klaus Klumpp
Klaus Klumpp Janssen (Belgium)
Joerg Heeren
Joerg Heeren Universität Hamburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens the door to diverse career options, many of which can be enhanced through related online degrees. For those interested in healthcare and patient support, online programs leading to becoming a child life specialist salary reflect the potential to work closely with children in medical settings, combining science with compassionate care.

Moreover, for individuals with a previous record, there are promising options available. Research highlights degrees felons can get, showing that many online microbiology-related fields remain accessible and supportive of second chances, providing valuable education and career growth opportunities.

For those interested in advanced medical roles, becoming a functional medicine np offers a pathway that integrates microbiological knowledge with holistic patient care, combining traditional and alternative medicine practices.

Lastly, some may pivot toward the administrative side of healthcare by pursuing certifications like the cpc, focusing on medical coding and billing. This also complements microbiology studies by ensuring accurate documentation and understanding of medical terminology.

Best Scientists Citing Maura Dandri

Trending Scientists

Recently Published Articles